Trial Profile
A prospective multicenter study of patients treated with molecular target therapy for hepatocellular carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2019
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Mar 2013 New trial record